文献速递流行病学与生物统计医学人工智能与信息学

竞争风险下动态治疗方案的估计与交叉验证

On estimation and cross-validation of dynamic treatment regimes with competing risks.
PubMed 文献 · Stat Med · 2022-09-02

该研究利用根特大学医院重症监护病房常规收集的观察性数据,针对急性肾损伤危重患者,基于血清钾、pH和液体平衡的时间更新水平,评估不同预设的肾脏替代治疗启动时机策略对30天ICU死亡率的影响,并采用逆概率加权Aalen-Johansen估计器和动态方案边际结构模型两种方法,同时提出一种易于实施的交叉验证技术评估最优动态治疗方案样本外性能。

要点

  • 基于常规收集的观察性数据可评估动态治疗方案对30天ICU死亡率的影响。
  • 采用逆概率加权Aalen-Johansen估计器和动态方案边际结构模型两种统计方法。
  • 提出一种易于实施的交叉验证技术评估最优动态治疗方案的样本外性能。

核心结论

  • 本工作展示了基于常规收集观察性数据的数据驱动医学决策支持的潜力。

研究设计与样本

  • 使用根特大学医院重症监护病房常规收集的观察性数据,针对急性肾损伤危重患者,评估基于血清钾、pH和液体平衡时间更新水平的预设肾脏替代治疗启动时机策略。

主要发现

  • 应用逆概率加权Aalen-Johansen估计器(非参数方法)和动态方案边际结构模型(半参数方法)评估特定动态治疗方案的影响,并将ICU出院作为竞争事件处理。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The optimal moment to start renal replacement therapy in a patient with acute kidney injury (AKI) remains a challenging problem in intensive care nephrology. Multiple randomized controlled trials have tried to answer this question, but these contrast only a limited number of treatment initiation strategies. In view of this, we use routinely collected observational data from the Ghent University Hospital intensive care units (ICUs) to investigate different prespecified timing strategies for renal replacement therapy initiation based on time-updated levels of serum potassium, pH, and fluid balance in critically ill patients with AKI with the aim to minimize 30-day ICU mortality. For this purpose, we apply statistical techniques for evaluating the impact of specific dynamic treatment regimes in the presence of ICU discharge as a competing event. We discuss two approaches, a nonparametric one - using an inverse probability weighted Aalen-Johansen estimator - and a semiparametric one - using dynamic-regime marginal structural models. Furthermore, we suggest an easy to implement cross-validation technique to assess the out-of-sample performance of the optimal dynamic treatment regime. Our work illustrates the potential of data-driven medical decision support based on routinely collected observational data.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Morzywołek P, Steen J, Van Biesen W, et al. On estimation and cross-validation of dynamic treatment regimes with competing risks. Stat Med. 2022. PMID: 36055675. doi:10.1002/sim.9568

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。